Shen Lian Biomedical
6880988.384.10% ( +0.33 )
Shen Lian Biomedical (688098)
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. The company off...
- Open
- 8.10
- High
- 8.44
- Low
- 8.10
- Prev. Close
- 8.05
- Volume
- 16.64K
- Turnover
- 13.89M
- Avg Price
- 8.35
- Bid/Ask Ratio
- -15.17%
- Amplitude
- 4.22%
- 52wk High
- 17.57
- Volume Ratio
- 0.77
- Turnover Ratio
- 0.41%
Shen Lian Biomedical Analyst Rating
View MoreForecast & Rating
May 13, 2023Price forecast
--100.00%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 26, 2025 at 02:37 AM
Shen Lian Biomedical released its performance for the first three quarters, with a net profit attributable to the parent company of 280,000 yuan, turning a profit compared to the same period last year
- Zhitong · Oct 22, 2025 at 06:19 AM
Shen Lian Biomedical: UBI plans to reduce its holdings by no more than 3% of shares
- Zhitong · Oct 16, 2025 at 08:44 PM
Innovative drug concept stocks continue to be active, HUAPONT LIFE SCIENCES hits the limit up
- Zhitong · Sep 8, 2025 at 02:51 AM
Shen Lian Biomedical has been approved for a veterinary drug product approval number
- Zhitong · Aug 31, 2025 at 04:54 AM
Shen Lian Biomedical: The Phase II clinical study of the innovative drug UB-221 injection has completed the enrollment of all subjects
- Zhitong · Aug 29, 2025 at 06:23 AM
Shen Lian Biomedical: Net loss of 12.8697 million yuan in the first half of 2025
